Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...
Januvia (sitagliptin) is a prescription drug that’s used to treat type 2 diabetes. This drug can interact with other medications. For example, Januvia can interact with other diabetes medications and ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. SITAGLIPTIN/METFORMIN XR MYLAN contains the active ingredients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results